HIV vaccine (Haikou VTI)

治疗用(重组核心抗原)艾滋病疫苗B.C

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV vaccine (Haikou VTI)
Drug Alias NameLFnp24B.CLFn-p24-B-C
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHaikou Vti Biological Institute
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHaikou Vti Biological Institute
Inactive CompaniesSouth China Center For Innovative Pharmaceuticals
Active IndicationsHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeN/A
Related LinksN/A